Differences in cardiovascular safety with non-steroidal anti-inflammatory drug therapy-A nationwide study in patients with osteoarthritis

Basic & Clinical Pharmacology & Toxicology Policy for Experimental and Clinical studies

(2018) Pernille Tveden-Nyborg et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Effect of Aspirin Coadministration on the Safety of Celecoxib, Naproxen, or Ibuprofen

(2018) Grant W. Reed et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The Cardiovascular Pharmacology of Nonsteroidal Anti-Inflammatory Drugs

(2017) Tilo Grosser et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data

(2017) Michèle Bally et al.   BMJ-British Medical Journal

Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data

(2017) Michèle Bally et al.   BMJ-British Medical Journal

Imprecision

(2016) Garret A. FitzGerald   CIRCULATION

Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis

(2016) Steven E. Nissen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Osteoarthritis and the risk of cardiovascular disease: a meta-analysis of observational studies

(2016) Haoran Wang et al.   Scientific Reports

The Danish National Patient Registry: a review of content, data quality, and research potential

(2015) Morten Schmidt et al.   Clinical Epidemiology

Relation of Nonsteroidal Anti-inflammatory Drugs to Serious Bleeding and Thromboembolism Risk in Patients With Atrial Fibrillation Receiving Antithrombotic Therapy

(2014) Morten Lamberts et al.   ANNALS OF INTERNAL MEDICINE

Antithrombotic Treatment in Patients With Heart Failure and Associated Atrial Fibrillation and Vascular Disease

(2014) Morten Lamberts et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

OARSI guidelines for the non-surgical management of knee osteoarthritis

(2014) T.E. McAlindon et al.   OSTEOARTHRITIS AND CARTILAGE

Epidemiology and burden of osteoarthritis

(2013) A. Litwic et al.   BRITISH MEDICAL BULLETIN

Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials

(2013)   LANCET

Use of Non-Steroidal Anti-Inflammatory Drugs That Elevate Cardiovascular Risk: An Examination of Sales and Essential Medicines Lists in Low-, Middle-, and High-Income Countries

(2013) Patricia McGettigan et al.   PLOS MEDICINE

Patterns of Therapy Switching, Augmentation, and Discontinuation After Initiation of Treatment With Select Medications in Patients With Osteoarthritis

(2011) Mugdha Gore et al.   CLINICAL THERAPEUTICS

Cardiovascular Risk with Non-Steroidal Anti-Inflammatory Drugs: Systematic Review of Population-Based Controlled Observational Studies

(2011) Patricia McGettigan et al.   PLOS MEDICINE

Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis

(2009) Matthew C. Becker et al.   AMERICAN HEART JOURNAL

Diabetes Patients Requiring Glucose-Lowering Therapy and Nondiabetics With a Prior Myocardial Infarction Carry the Same Cardiovascular Risk

(2008) Tina Ken Schramm et al.   CIRCULATION